Skip to main content
Value of Vaccines Q2 2022

Vaccines are making an impact through vaccinations

The challenge is not getting hold of COVID-19 vaccines, it is getting vaccines into arms. The healthcare community is continuing to showcase the value of vaccines throughout one’s life course. Over the last two years, the global healthcare community’s efforts in mounting a response to COVID-19 have materialised. This pandemic has brought home the power … Continued
Value of Vaccines Q4 2021

Learning lessons from the implementation of COVID-19 vaccinations

The COVID-19 vaccination programme provides important policy lessons about how to promote vaccine uptake and reduce inequalities in access. The COVID-19 vaccination programme – the first ever to vaccinate the entire adult population of the UK – may be the start of a new era of how we regard vaccines as a public health tool. However, … Continued
Value of Vaccines 2021

Keeping vaccines as affordable as generic medicines: a matter of life and death

Fundamental differences in developing vaccines and medicines mean that second generation vaccines are never going be as cheap as generic drugs, but there are still ways to reduce their cost. Generic medicines – budget versions of brand-name drugs – are often quite literally a lifesaver because they are affordable. Vaccines are just as critical, protecting … Continued